Daneng Li, Neal Shiv Chawla, Andrea S. Teague, Koho Iizuka, Hong Tang, Varun N. Kapoor, Eric Cheung. "A randomized phase 2 study of casdozokitug, an IL-27 targeting antibody, in combination with toripalimab plus bevacizumab in patients with unresectable and/or locally advanced or metastatic hepatocellular carcinoma.." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco.2025.43.16_suppl.tps4217